However, there is one non-pharmaceutical IPO that could pique some interest. Specifically, billionaire and Virgin Group founder Richard Branson is behind a new Florida-based railway company that will be launching a $500 mln IPO this week. As the first new major private passenger intercity railroad in the United States in over a century, this is a unique deal that could generate some interest, especially since IPO investors have had so little to pick and choose from during the past few months.
Monday, February 11:
- No IPOs expected.
Tuesday, February 12:
- BankFlorida (BFL): Originally expected to price last October, the Florida-state chartered community bank based in Palm Beach Gardens, FL is expected to price its 4.2 mln share IPO within a range of $9.50-$10.50. Originally, the company was looking to sell 6.2 mln shares within a range of $10-$11.
Wednesday, February 13:
- Virgin Trains (VTUS): The owner and operator of an express passenger rail system in Florida is expected to price its 28.3 mln share IPO within a range of $17-$19.
Thursday, February 14:
- Avedro (AVDR): The commercial stage ophthalmic medical technology company focused on treating corneal ectatic disorders is expected to price its 5.0 mln share IPO within a range of $14-$16.
- Cibus Global (CBUS): The biotech company using advanced technologies to develop desirable plant traits for global seed industry is expected to price its 6.7 mln share IPO within a range of $14-$16.
- TCR2 Therapeutics (TCRR): The immunotherapy company developing T Cell therapies for patients suffering from cancer is expected to price its 5.0 mln share IPO within a range of $14-$16.
Friday, February 15:
- Stealth Biotherapeutics (MITO): The clinical stage biotech company focused on developing therapies for diseases involving mitochondrial dysfunction is expected to price its 6.2 mln share IPO within a range of $12-$14.